Clincosm LogoSign in Get a demo

progressive disease

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease Trial in France (Lutathera)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Angers, France
  • +21 more
Aug 2, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory

Active, not recruiting
Has Results
  • Castration Levels of Testosterone
  • +9 more
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

MDS, Progressive Disease Trial in Buffalo, Winston-Salem (CPI-613, Hydroxychloroquine)

Withdrawn
  • Myelodysplastic Syndromes
  • Progressive Disease
  • Buffalo, New York
  • +1 more
Apr 8, 2021

Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer Trial in Meldola (Pembrolizumab, Autologous dendritic cells,

Recruiting
  • Mesothelioma, Malignant
  • +3 more
  • Meldola, FC, Italy
    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
Feb 25, 2021

Head and Neck Tumors, Tumor Metastasis, Recurrent Disease Trial in France (BKM120)

Completed
  • Head and Neck Neoplasms
  • +3 more
  • Bordeaux, France
  • +8 more
Jun 20, 2019